Mehmet Akce
Clinical trials sponsored by Mehmet Akce, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug cocktail targets rare liver cancer in 29-Patient trial Results expected May 2027 (estimated)
- New combo therapy targets rare bile duct cancer gene Results expected Jul 2027 (estimated)